Ikarian Capital, LLC
Top Portfolio Positions
134 positions ·
$1,088,185,757 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
2,656,378 | $140,044,248 | 12.87% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
1,242,472 | $81,891,329 | 7.53% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
100,000 | $57,718,000 | 5.30% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
1,365,795 | $52,064,105 | 4.78% | |
| ABVX |
Abivax S.A.
Healthcare
|
350,935 | $39,076,612 | 3.59% | |
| ALMS |
Alumis Inc.
Healthcare
|
1,478,148 | $32,563,600 | 2.99% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
500,000 | $30,325,000 | 2.79% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
878,015 | $26,691,656 | 2.45% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
258,142 | $25,104,309 | 2.31% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
428,682 | $24,910,711 | 2.29% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PEPG
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $531,000 | 300,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $791,482 | 447,165 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,953,000 | 300,000 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $2,911,044 | 447,165 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,476,167 | 535,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $166,500 | 150,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $210,750 | 150,000 | Shares | Sole | 2025-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||